Description

Uses, Advantages, Dosage, Side Effects, and Precaution of Tagrix 80mg

SEO Focus Keyword: Tagrix 80mg .

Tagrix 80mg is an oral cancer medicine with the active ingredient osimertinib. It is a member of a class of drugs known as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Doctors may prescribe osimertinib for some kinds of non–small cell lung cancer (NSCLC) when the tumour has certain EGFR mutations. Tagrix 80mg contains osimertinib mesylate, which is equivalent to 80 mg of osimertinib.

What Is Tagrix 80mg?

Tagrix 80mg is a targeted cancer treatment. It is a film-coated tablet. Osimertinib, unlike traditional chemotherapy which can affect many fast-dividing cells, targets abnormal EGFR signalling involved in the growth of some lung cancer cells. It can inhibit several mutant forms of EGFR including mutations such as T790M, L858R and exon 19 deletions.

This targeting means doctors often choose patients for treatment according to the type of cancer and molecular test results. So patients should not take Tagrix 80mg without specialist medical advice and proper testing.

Tagrix 80mg is used for the treatment of erectile dysfunction.

Doctors may prescribe osimertinib for adults with certain EGFR-mutated NSCLC. Approved indications include some patients receiving treatment following surgery, patients with locally advanced disease not suitable for surgical treatment following chemoradiation, first-line treatment of advanced or metastatic EGFR-mutated NSCLC, and selected patients with cancer progression following another EGFR tyrosine kinase inhibitor.

Furthermore, osimertinib has been explored in different clinical settings in EGFR-mutated lung cancer. The precise indication is based on the patient’s cancer stage, mutation status, prior treatment and local prescribing guidance.

How Tagrix 80mg Works?

The active ingredient osimertinib blocks abnormal EGFR signals that may cause cancer cells to grow and survive. It binds irreversibly to certain mutant EGFR proteins. And then it can interfere with signalling pathways that promote growth of tumour.

However, Tagrix 80mg is not effective for all types of lung cancer. Molecular testing is important as treatment decisions are based on genetic features of the tumour.

Tagrix 80 mg dosage

The usual dose of osimertinib that is recommended is 80 mg once a day. The proper schedule is determined by the diagnosis, treatment plan, and medical history of the patient. As a rule, Tagrix can be taken with or without food.

Follow the directions on the medicine label very carefully. Do not change the dose or stop treatment by yourself. If you do miss a dose, follow the advice of your oncology team and do not take extra tablets to make up for missed doses. Therapy may be continued until disease progression or unacceptable toxicity, depending upon the clinical situation.

Side effects Common

Side effects may occur with Tagrix 80mg, as with other cancer medicines. The most frequently reported reactions with osimertinib were diarrhoea, rash, dry skin and nail changes.

Other treatment-related effects Some people may have other effects such as tiredness, reduced appetite, mouth problems and other effects. So, be sure to tell your doctor about any new or persistent symptoms to make sure that your treatment is properly monitored.

Warnings and Precautions Serious

Tagrix 80mg is a targeted therapy and may cause serious reactions. Interstitial lung disease or pneumonitis, which can cause breathing difficulties, have been associated with osimertinib. It can also prolong the QT interval on an electrocardiogram and may have an effect on heart function.

Get medical help right away if you have serious or worsening shortness of breath, chest symptoms, fainting, or other serious reactions. Your doctor may also do heart tests and other monitoring during treatment when appropriate.

Special care is needed during pregnancy, as osimertinib can harm the foetus. Patients of childbearing potential should discuss effective contraception with their healthcare professional. Prescribing information does not recommend breastfeeding during treatment.

Interactions With Other Drugs

Tagrix 80mg may affect other medicines you are taking. Strong inducers of CYP3A may decrease osimertinib levels while some inhibitors of CYP3A may increase osimertinib levels. So before you begin treatment, give your doctor a complete list of prescription medications, over-the-counter products and supplements.

Questions & Answers

What is Tagrix 80 mg?

Tagrix 80mg is not a traditional cytotoxic chemotherapy drug, it contains osimertinib, a targeted EGFR tyrosine kinase inhibitor.

Is Tagrix 80mg for everyone with lung cancer?

No Osimertinib is for use in selected patients with specific EGFR-associated forms of NSCLC. Before treatment, testing and specialist assessment are important

How often is Tagrix 80mg taken?

The usual dose of osimertinib is 80 mg once a day but your oncologist will decide the dose and how long you will need to take it based on your condition.

Final thought

Tagrix 80mg contains osimertinib, a leading targeted therapy for selected patients with EGFR-mutated non-small cell lung cancer. The targeted mechanism enables doctors to target specific molecules within the cancer instead of a non-selective approach. But it is a prescription drug for cancer and requires proper mutation testing, medical supervision, and monitoring of side effects.